Dopamine
From DrugPedia: A Wikipedia for Drug discovery
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 46: | Line 46: | ||
|- | |- | ||
|} | |} | ||
| - | Physical Property | + | |
| + | {| border="1;width:100%; height:200px;style=text-align:center" | ||
| + | |+'''Physiochemical properties of Dopamine:''' | ||
| + | |- | ||
| + | ! style="background:brown; color:white" |Physical Property | ||
| + | ! style="background:brown; color:white" |Value | ||
| + | ! style="background:brown; color:white" |Units | ||
| + | ! style="background:brown; color:white" |Temp (deg C) | ||
| + | ! style="background:brown; color:white" |Source | ||
| + | |- | ||
|Melting Point | |Melting Point | ||
|128 | |128 | ||
| - | |deg C | + | |deg C |
| + | | | ||
|EXP | |EXP | ||
|- | |- | ||
|pKa Dissociation Constant | |pKa Dissociation Constant | ||
|8.93 | |8.93 | ||
| - | |(none) | + | |(none) |
| + | | | ||
|EXP | |EXP | ||
|- | |- | ||
|log P (octanol-water) | |log P (octanol-water) | ||
| - | | | + | |0.98 |
| - | |(none) | + | |(none) |
| + | | | ||
|EXP | |EXP | ||
|- | |- | ||
| Line 87: | Line 99: | ||
|- | |- | ||
|} | |} | ||
| - | Organism | + | {| border="1;width:100%; height:200px;style=text-align:center" |
| + | |+'''Toxicity:''' | ||
| + | |- | ||
| + | ! style="background:brown; color:white" |Organism | ||
| + | ! style="background:brown; color:white" |Test Type | ||
| + | ! style="background:brown; color:white" |Route | ||
| + | ! style="background:brown; color:white" |Reported Dose (Normalized Dose) | ||
| + | ! style="background:brown; color:white" |Effect | ||
| + | ! style="background:brown; color:white" |Source | ||
| + | |- | ||
|mammal (species unspecified) | |mammal (species unspecified) | ||
|LD50 | |LD50 | ||
|unreported | |unreported | ||
| - | |1120mg/kg (1120mg/kg) | + | |1120mg/kg (1120mg/kg) |
| + | | | ||
|Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. Vol. 24(4), Pg. 42, 1990. | |Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. Vol. 24(4), Pg. 42, 1990. | ||
|- | |- | ||
Current revision
Dopamine Pubchem(681)
One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action.
Therapeutic Indications
- Hypotension
- Parkinson Disease
Therapeutic Uses
- cns agent
- cardiovascular agent
KEGG Pathway(C03758,D07870)
- Tyrosine metabolism
- Indole and ipecac alkaloid biosynthesis
- Alkaloid biosynthesis I
- Neuroactive ligand-receptor interaction
- Gap junction
- Parkinson's disease
Activity Antihypotensive,Cardiac stimulant, cardiotonic
| MMDB ID | PDB ID | Reference |
|---|---|---|
| 34790 | 2A3R | Lu JH, Li HT, Liu MC, Zhang JP, Li M, An XM, Chang WRCrystal structure of human sulfotransferase SULT1A3 in complex with dopamine and 3'-phosphoadenosine 5'-phosphateBiochem. Biophys. Res. Commun. v335, p.417-423 |
| 58509 | 5PAH | Erlandsen H, Flatmark T, Stevens RC, Hough ECrystallographic analysis of the human phenylalanine hydroxylase catalytic domain with bound catechol inhibitors at 2.0 A resolutionBiochemistry v37, p.15638-15646 |
| 65041 | 2QMZ | Fu Y, Buryanovskyy L, Zhang Z, 2007/7/17 |
| 65825 | 2VQ5 | Ilari A, Franceschini S, Bonamore A, Boffi A, 2008/3/11 |
| Physical Property | Value | Units | Temp (deg C) | Source |
|---|---|---|---|---|
| Melting Point | 128 | deg C | EXP | |
| pKa Dissociation Constant | 8.93 | (none) | EXP | |
| log P (octanol-water) | 0.98 | (none) | EXP | |
| Water Solubility | 1.00E+06 | mg/L | 25 | EST |
| Vapor Pressure | 2.57E-05 | mm Hg | 25 | EST |
| Henry's Law Constant | 8.79E-15 | atm-m3/mole | 25 | EST |
| Atmospheric OH Rate Constant | 9.01E-11 | cm3/molecule-sec | 25 | EST |
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mammal (species unspecified) | LD50 | unreported | 1120mg/kg (1120mg/kg) | Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU. Vol. 24(4), Pg. 42, 1990. | |
| mouse | LD50 | intracervical | 74mg/kg (74mg/kg) | BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY) | Tohoku Yakka Daigaku Kenkyu Nempo. Annual Report of the Tohoku College of Pharmacy. Vol. 27, Pg. 131, 1980. |
| mouse | LD50 | intraperitoneal | 950mg/kg (950mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION BLOOD: HEMORRHAGE | Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 835, 1974. |
| mouse | LD50 | intravenous | 59mg/kg (59mg/kg) | SENSE ORGANS AND SPECIAL SENSES: OTHER CHANGES: OLFACTION
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION BLOOD: HEMORRHAGE | Oyo Yakuri. Pharmacometrics. Vol. 8, Pg. 835, 1974. |
| rat | LD50 | intraperitoneal | 163mg/kg (163mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES
KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Toxicology and Applied Pharmacology. Vol. 88, Pg. 433, 1987. |
